Add-on linagliptin improves glucose control in persistent IGT
After 12 months of metformin and consistent lifestyle changes, patients who still showed impaired glucose tolerance (IGT) seem to benefit from the addition of linagliptin to their regimen, leading to improvements in glucose concentrations and pancreatic β-cell function, a recent study has found.
